Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 03:56 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | Turner William D. | Officer; Chief Regulatory Officer | Pharmaceutical Preparations | SALE | $41.98 | 2,187 | $91,819 | 45,313 | -4.6% |
| 2025-12-18 00:05 | 2025-12-15 | VERA | Vera Therapeutics, Inc. | Turner William D. | Officer; Chief Regulatory Officer | Pharmaceutical Preparations | OPT+S | $50.08 | 10,000 | $500,767 | 22,500 | -30.8% |
| 2025-12-11 00:05 | 2025-12-08 | VERA | Vera Therapeutics, Inc. | Turner William D. | Officer; Chief Regulatory Officer | Pharmaceutical Preparations | OPT+S | $45.31 | 10,000 | $453,053 | 22,500 | -30.8% |
| 2025-12-05 00:05 | 2025-12-03 | VERA | Vera Therapeutics, Inc. | Turner William D. | Officer; Chief Regulatory Officer | Pharmaceutical Preparations | OPT+S | $40.00 | 10,000 | $400,000 | 22,500 | -30.8% |
| 2022-04-07 23:12 | 2022-04-05 | SRRA | N/A | Turner William D. | Officer; Chief Reg & Tech Ops Officer | Other | OPT+S | $37.25 | 6,447 | $240,119 | 0 | -100.0% |
| 2022-03-22 23:15 | 2022-03-18 | SRRA | N/A | Turner William D. | Officer; Chief Reg & Tech Ops Officer | Other | OPT+S | $37.05 | 100 | $3,705 | 0 | -100.0% |
| 2022-03-18 01:33 | 2022-03-17 | SRRA | N/A | Turner William D. | Officer; Chief Reg & Tech Ops Officer | Other | OPT+S | $37.06 | 3,453 | $127,954 | 0 | -100.0% |
| 2022-02-09 00:03 | 2022-02-07 | SRRA | N/A | Turner William D. | Officer; Chief Reg & Tech Ops Officer | Other | OPT+S | $32.32 | 10,000 | $323,225 | 0 | -100.0% |
| 2022-01-29 00:39 | 2022-01-26 | SRRA | N/A | Turner William D. | Officer; Chief Reg & Tech Ops Officer | Other | OPT+S | $27.05 | 5,000 | $135,250 | 0 | -100.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.